查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1434238

血液培養測試市場：按產品、技術、應用和最終用戶分類 - 2023-2030 年全球預測

Blood Culture Test Market by Product (Consumable, Instrument, Software and Services), Technology (Culture-Based Technology, Molecular Technology, Proteomics Technology), Application, End User - Global Forecast 2023-2030
出版日期: | 出版商: 360iResearch | 英文 189 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計2022年血液培養檢測市場規模為39.9億美元，2023年達42.3億美元，預計到2030年將達到64.4億美元，複合年成長率為6.17%。

全球血液培養檢測市場

主要市場統計
基準年[2022] 39.9億美元
預計年份 [2023] 42.3億美元
預測年份 [2030] 64.4億美元
複合年成長率（%） 6.17%
血液培養檢測市場-IMG1

血液培養測試是一種臨床診斷程序，用於檢測血液中是否存在細菌和真菌等微生物。當醫療保健提供者懷疑患者患有全身性感染疾病（例如敗血症或菌血症）時，就會進行血液培養測試。該測試包括從患者身上採集血液樣本，並將其在受控環境中培養，以促進存在的任何微生物的生長。血液培養檢測是現代醫學管理感染疾病的重要工具，通常在醫院和參考實驗室進行。隨著老年人口的增加，血流感染疾病和敗血症的盛行率不斷增加，增加了對血液培養檢測的需求。此外，醫療保健基礎設施和診斷技術的改進以及對早期和快速診斷的更多關注增加了血液培養檢測的可及性和使用。然而，與先進血液培養檢測技術相關的高成本可能會限制市場成長。儘管如此，快速診斷測試的發展以縮短獲得結果的時間，以及分子診斷的進步以準確識別病原體，可能為市場創造有利的形勢。

區域洞察

美洲的血液培養檢測市場正在顯著成長，美國對血液培養檢測產品的消費和生產做出了巨大貢獻。敗血症高發生率、完善的醫療基礎設施以及成熟市場參與者等因素正在促進該地區的成長。自動化血液培養系統的採用以及快速診斷工具的日益重要性進一步增加了需求。在歐洲、中東和非洲，由於每個國家的經濟狀況和醫療體係不同，血液培養檢測的市場形勢也多元。歐洲市場正在經歷顯著成長，重點是醫療保健環境中的感染控制。同時，中東和非洲是新興市場，醫療基礎設施投資不斷增加。歐洲市場受益於強力的醫療保健政策、高額醫療保健支出以及全球診斷公司的存在。疾病監測計劃和遏制抗菌素抗藥性的努力也促進了該地區的市場成長。在亞太地區，由於醫療設施的快速改善、健康意識的提高以及政府醫療保健支出的增加，血液培養檢測市場預計將呈現快速成長。龐大的人口基數、感染疾病的流行以及不斷增加的醫院和臨床診斷實驗室數量進一步促進了亞太市場的成長。

FPNV定位矩陣

FPNV定位矩陣對於評估血液培養檢測市場至關重要。我們檢視與商務策略和產品滿意度相關的關鍵指標，以對供應商進行全面評估。這種詳細的分析使用戶能夠根據自己的要求做出明智的決策。根據評級，供應商被分為四個不同的象限，代表不同的成功程度：前沿 (F)、探路者 (P)、利基 (N) 或重要 (V)。

市場佔有率分析

市場佔有率分析是一種綜合工具，可以對血液培養測試市場供應商的現狀進行深入而深入的研究。仔細比較和分析供應商在整體收益、客戶群和其他關鍵指標方面的貢獻，幫助企業更好地了解其績效以及在爭奪市場佔有率時面臨的挑戰。此外，該分析還提供了對該行業競爭特徵的寶貴見解，包括在研究基準年期間觀察到的累積、分散優勢和合併特徵等因素。這種擴展的詳細程度使供應商能夠做出更明智的決策並制定有效的策略，以獲得市場競爭優勢。

本報告在以下方面提供了寶貴的見解：

1-市場滲透率：顯示主要企業提供的有關市場的全面資訊。

2- 市場發現：深入研究盈利的新興市場並分析其在成熟細分市場的滲透率。

3- 市場多樣性：提供有關新產品發布、未開發地區、最新發展和投資的詳細資訊。

4- 競爭評估和情報：對主要企業的市場佔有率、策略、產品、認證、監管核准、專利形勢和製造能力進行全面評估。

5- 產品開發與創新：提供對未來技術、研發活動和突破性產品開發的智慧見解。

本報告解決了以下關鍵問題：

1-血液培養檢測市場的市場規模與預測是多少？

2-在血液培養測試市場的預測期內，有哪些產品、細分市場、應用和領域需要考慮投資？

3-血液培養檢測市場的技術趨勢和法律規範是什麼？

4-血液培養檢測市場主要供應商的市場佔有率是多少？

5- 進入血液培養檢測市場適合的模式和策略措施有哪些？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 血流感染疾病和感染疾病需要照護現場和快速診斷檢測
      • 公共和私人醫療保健成本增加，特別是為了改善診斷
      • 政府對臨床和實驗室報銷政策的支持和核准
    • 抑制因素
      • 與受污染的血液培養相關的潛在風險
    • 機會
      • 推動診斷測試和方法的新研發 (R&D) 活動
      • 更多採用自動化血液培養測試
    • 任務
      • 政府對血液培養開發和生產有嚴格的規範
  • 市場區隔分析
    • 產品：軟體的不斷進步，增強了血液培養資料分析和報告的自動化
    • 技術：病原體的快速和特異性檢測增加了分子技術的重要性
    • 用途：血流感染疾病的流行促進血液培養檢測的使用
    • 最終用戶：學術研究機構更多地使用血液培養測試，以提高病原體檢測的特異性和靈敏度
  • 市場趨勢分析
  • COVID-19 的累積影響
  • 俄羅斯-烏克蘭衝突的累積影響
  • 高通膨的累積效應
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 法律規範
  • 客戶客製化

第6章血液培養檢測市場：依產品

  • 消耗品
  • 裝置
  • 軟體和服務

第7章血液培養檢測市場：依技術分類

  • 基於文化的技術
  • 分子技術
  • 蛋白質體學技術

第8章血液培養檢測市場：依應用分類

  • 菌血症
  • 真菌病
  • 分枝桿菌檢測

第9章血液培養檢測市場：依最終用戶分類

  • 學術研究所
  • 醫院實驗室
  • 參考實驗室

第10章美洲血液培養檢測市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太地區血培養檢測市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章 歐洲、中東、非洲血液培養檢測市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭形勢

  • FPNV定位矩陣
  • 市場佔有率分析：主要企業
  • 主要企業競爭情境分析
    • 合約、合作和夥伴關係
    • 新產品發布和功能增強

第14章競爭產品組合

  • 主要公司簡介
    • Abbott Laboratories
    • Anaerobe Systems, Inc.
    • Autobio Diagnostics Co., Ltd.
    • Becton, Dickinson and Company
    • BINDER GmbH
    • Biobase Biodusty（Shandong）, Co., Ltd.
    • Biomerieux SA
    • Bruker Corporation
    • Danaher Corporation
    • Devyser AB
    • Eli Lilly and Company
    • F. Hoffmann-La Roche Ltd.
    • HiMedia Laboratories Pvt. Ltd.
    • Juno Diagnostics, Inc.
    • Neogen Corporation
    • Novartis AG
    • OpGen, Inc.
    • Scenker Biological Technology Co., Ltd.
    • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
    • Siemens Healthineers AG
    • T2 Biosystems, Inc.
    • Terumo Corporation
    • Thermo Fisher Scientific, Inc.
    • ZeptoMetrix Corporation
  • 主要產品系列

第15章附錄

  • 討論指南
  • 關於許可證和定價
Product Code: MRR-035DA3C63738

[189 Pages Report] The Blood Culture Test Market size was estimated at USD 3.99 billion in 2022 and expected to reach USD 4.23 billion in 2023, at a CAGR 6.17% to reach USD 6.44 billion by 2030.

Global Blood Culture Test Market

KEY MARKET STATISTICS
Base Year [2022] USD 3.99 billion
Estimated Year [2023] USD 4.23 billion
Forecast Year [2030] USD 6.44 billion
CAGR (%) 6.17%
Blood Culture Test Market - IMG1

The blood culture test is a clinical diagnostic procedure utilized to detect the presence of microorganisms, such as bacteria or fungi, in the blood. A blood culture test is ordered when a healthcare provider suspects that a patient is suffering from a systemic infection, such as septicemia or bacteremia. This test includes drawing a blood sample from the patient and incubating it in a controlled environment to promote the growth of any microorganisms present. The blood culture test is a vital tool in modern medicine for managing infectious diseases and is routinely performed in hospitals and reference laboratories. The rising prevalence of bloodstream infections and sepsis with an increasing aging population drives the need for blood culture tests. Moreover, improvements in healthcare infrastructure and diagnostic technologies coupled with an increasing focus on early and rapid diagnosis have increased the accessibility and use of blood culture tests. However, the high cost associated with advanced blood culture testing technologies may restrict the market growth. Nevertheless, the development of rapid diagnostic tests to decrease the time-to-results and advancements in molecular diagnostics for precise pathogen identification may create an opportunistic landscape for the market.

Regional Insights

The market for blood culture tests in the Americas is growing significantly, with the United States contributing majorly to both the consumption and production of blood culture test products. Factors such as a high incidence rate of sepsis, well-established healthcare infrastructure, and the presence of established market players contribute to the growth in this region. The adoption of automated blood culture systems and the growing importance of rapid diagnostic tools are driving the demand further. The EMEA region exhibits a diverse market landscape for blood culture tests owing to variances in economic conditions and healthcare systems across countries. Europe represents a significant growth of the market, with a strong emphasis on infection control measures in healthcare settings. The Middle East and Africa, on the other hand, are emerging markets with increasing investments in healthcare infrastructure. The European market benefits from robust healthcare policies, high healthcare expenditure, and the presence of global diagnostic companies. Disease surveillance programs and initiatives to curb antimicrobial resistance are also aiding in market growth in this region. The Asia-Pacific region is anticipated to exhibit a rapid growth rate in the blood culture test market attributed to rapidly improving healthcare facilities, growing health awareness, and increased government healthcare expenditures. The vast population base, the increasing prevalence of infectious diseases, and the rising number of hospitals and clinical diagnostic laboratories are further contributing to the growth of the market in the APAC.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Blood Culture Test Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Blood Culture Test Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Blood Culture Test Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Anaerobe Systems, Inc., Autobio Diagnostics Co., Ltd., Becton, Dickinson and Company, BINDER GmbH, Biobase Biodusty(Shandong), Co., Ltd., Biomerieux SA, Bruker Corporation, Danaher Corporation, Devyser AB, Eli Lilly and Company, F. Hoffmann-La Roche Ltd., HiMedia Laboratories Pvt. Ltd., Juno Diagnostics, Inc., Neogen Corporation, Novartis AG, OpGen, Inc., Scenker Biological Technology Co., Ltd., Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Siemens Healthineers AG, T2 Biosystems, Inc., Terumo Corporation, Thermo Fisher Scientific, Inc., and ZeptoMetrix Corporation.

Market Segmentation & Coverage

This research report categorizes the Blood Culture Test Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product
    • Consumable
    • Instrument
    • Software and Services
  • Technology
    • Culture-Based Technology
    • Molecular Technology
    • Proteomics Technology
  • Application
    • Bacteremia
    • Fungemia
    • Mycobacterial Detection
  • End User
    • Academic Research Laboratories
    • Hospital Laboratories
    • Reference Laboratories
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Blood Culture Test Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Blood Culture Test Market?

3. What are the technology trends and regulatory frameworks in the Blood Culture Test Market?

4. What is the market share of the leading vendors in the Blood Culture Test Market?

5. Which modes and strategic moves are suitable for entering the Blood Culture Test Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Blood Culture Test Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Need for Point-of-Care and Rapid Diagnostic Tests Owing to the Growing Prevalence of Bloodstream Infections and Infectious Diseases
      • 5.1.1.2. Rising Public and Private Healthcare Expenditure Specifically for the Improved Diagnosis
      • 5.1.1.3. Government Support and Approval Along with Clinical and Lab Reimbursement Policies
    • 5.1.2. Restraints
      • 5.1.2.1. Potential Risk Associated with Contaminated Blood Culture
    • 5.1.3. Opportunities
      • 5.1.3.1. Emerging Research and Development (R&D) Activities in the Advancement of Diagnostic Tests and Methods
      • 5.1.3.2. Rising Adoption of Automated Blood Culture Tests
    • 5.1.4. Challenges
      • 5.1.4.1. Strict Government Norms in the Development and Production of Blood Cultures
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Ongoing advancement in the softwares to enhance automation in blood culture data analysis and reporting.
    • 5.2.2. Technology: Growing significance of molecular technology due to its rapid and specific detection of pathogens
    • 5.2.3. Application: Increasing prevalence of bloodstream infections driving the utilization of blood culture test
    • 5.2.4. End User: Rising utilization of blood culture test by academic research laboratories for to enhance the specificity and sensitivity of pathogen detection
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of COVID-19
  • 5.5. Cumulative Impact of Russia-Ukraine Conflict
  • 5.6. Cumulative Impact of High Inflation
  • 5.7. Porter's Five Forces Analysis
    • 5.7.1. Threat of New Entrants
    • 5.7.2. Threat of Substitutes
    • 5.7.3. Bargaining Power of Customers
    • 5.7.4. Bargaining Power of Suppliers
    • 5.7.5. Industry Rivalry
  • 5.8. Value Chain & Critical Path Analysis
  • 5.9. Regulatory Framework
  • 5.10. Client Customization

6. Blood Culture Test Market, by Product

  • 6.1. Introduction
  • 6.2. Consumable
  • 6.3. Instrument
  • 6.4. Software and Services

7. Blood Culture Test Market, by Technology

  • 7.1. Introduction
  • 7.2. Culture-Based Technology
  • 7.3. Molecular Technology
  • 7.4. Proteomics Technology

8. Blood Culture Test Market, by Application

  • 8.1. Introduction
  • 8.2. Bacteremia
  • 8.3. Fungemia
  • 8.4. Mycobacterial Detection

9. Blood Culture Test Market, by End User

  • 9.1. Introduction
  • 9.2. Academic Research Laboratories
  • 9.3. Hospital Laboratories
  • 9.4. Reference Laboratories

10. Americas Blood Culture Test Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Blood Culture Test Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Blood Culture Test Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. FPNV Positioning Matrix
  • 13.2. Market Share Analysis, By Key Player
  • 13.3. Competitive Scenario Analysis, By Key Player
    • 13.3.1. Agreement, Collaboration, & Partnership
      • 13.3.1.1. Universal DX Announces Strategic Collaboration with Quest Diagnostics to Bring Advanced Colorectal Cancer Screening Blood Test to Patients and Providers in the United States
      • 13.3.1.2. BD, Magnolia Medical Technologies Announce Commercial Collaboration to Help Reduce Blood Culture Contamination and Improve Testing Accuracy
    • 13.3.2. New Product Launch & Enhancement
      • 13.3.2.1. Accelerate Diagnostics Launches Arc System for Use in Blood Culture Test

14. Competitive Portfolio

  • 14.1. Key Company Profiles
    • 14.1.1. Abbott Laboratories
    • 14.1.2. Anaerobe Systems, Inc.
    • 14.1.3. Autobio Diagnostics Co., Ltd.
    • 14.1.4. Becton, Dickinson and Company
    • 14.1.5. BINDER GmbH
    • 14.1.6. Biobase Biodusty(Shandong), Co., Ltd.
    • 14.1.7. Biomerieux SA
    • 14.1.8. Bruker Corporation
    • 14.1.9. Danaher Corporation
    • 14.1.10. Devyser AB
    • 14.1.11. Eli Lilly and Company
    • 14.1.12. F. Hoffmann-La Roche Ltd.
    • 14.1.13. HiMedia Laboratories Pvt. Ltd.
    • 14.1.14. Juno Diagnostics, Inc.
    • 14.1.15. Neogen Corporation
    • 14.1.16. Novartis AG
    • 14.1.17. OpGen, Inc.
    • 14.1.18. Scenker Biological Technology Co., Ltd.
    • 14.1.19. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
    • 14.1.20. Siemens Healthineers AG
    • 14.1.21. T2 Biosystems, Inc.
    • 14.1.22. Terumo Corporation
    • 14.1.23. Thermo Fisher Scientific, Inc.
    • 14.1.24. ZeptoMetrix Corporation
  • 14.2. Key Product Portfolio

15. Appendix

  • 15.1. Discussion Guide
  • 15.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. BLOOD CULTURE TEST MARKET RESEARCH PROCESS
  • FIGURE 2. BLOOD CULTURE TEST MARKET SIZE, 2022 VS 2030
  • FIGURE 3. BLOOD CULTURE TEST MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. BLOOD CULTURE TEST MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 5. BLOOD CULTURE TEST MARKET SIZE, BY REGION, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 6. BLOOD CULTURE TEST MARKET DYNAMICS
  • FIGURE 7. BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2022 VS 2030 (%)
  • FIGURE 8. BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 9. BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2022 VS 2030 (%)
  • FIGURE 10. BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 11. BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
  • FIGURE 12. BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2022 VS 2030 (%)
  • FIGURE 14. BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 15. AMERICAS BLOOD CULTURE TEST MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
  • FIGURE 16. AMERICAS BLOOD CULTURE TEST MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 17. UNITED STATES BLOOD CULTURE TEST MARKET SIZE, BY STATE, 2022 VS 2030 (%)
  • FIGURE 18. UNITED STATES BLOOD CULTURE TEST MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 19. ASIA-PACIFIC BLOOD CULTURE TEST MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
  • FIGURE 20. ASIA-PACIFIC BLOOD CULTURE TEST MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA BLOOD CULTURE TEST MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA BLOOD CULTURE TEST MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 23. BLOOD CULTURE TEST MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 24. BLOOD CULTURE TEST MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. BLOOD CULTURE TEST MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. BLOOD CULTURE TEST MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL BLOOD CULTURE TEST MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 6. BLOOD CULTURE TEST MARKET SIZE, BY CONSUMABLE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. BLOOD CULTURE TEST MARKET SIZE, BY INSTRUMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. BLOOD CULTURE TEST MARKET SIZE, BY SOFTWARE AND SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 10. BLOOD CULTURE TEST MARKET SIZE, BY CULTURE-BASED TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. BLOOD CULTURE TEST MARKET SIZE, BY MOLECULAR TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. BLOOD CULTURE TEST MARKET SIZE, BY PROTEOMICS TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 14. BLOOD CULTURE TEST MARKET SIZE, BY BACTEREMIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. BLOOD CULTURE TEST MARKET SIZE, BY FUNGEMIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. BLOOD CULTURE TEST MARKET SIZE, BY MYCOBACTERIAL DETECTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 18. BLOOD CULTURE TEST MARKET SIZE, BY ACADEMIC RESEARCH LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. BLOOD CULTURE TEST MARKET SIZE, BY HOSPITAL LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. BLOOD CULTURE TEST MARKET SIZE, BY REFERENCE LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS BLOOD CULTURE TEST MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 30. BRAZIL BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 34. CANADA BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 38. MEXICO BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 39. MEXICO BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 40. MEXICO BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 41. MEXICO BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 42. UNITED STATES BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 43. UNITED STATES BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES BLOOD CULTURE TEST MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 47. ASIA-PACIFIC BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 48. ASIA-PACIFIC BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC BLOOD CULTURE TEST MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 52. AUSTRALIA BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 53. AUSTRALIA BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 54. AUSTRALIA BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. AUSTRALIA BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 56. CHINA BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 57. CHINA BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 58. CHINA BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. CHINA BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 60. INDIA BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 61. INDIA BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 62. INDIA BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. INDIA BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 64. INDONESIA BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 65. INDONESIA BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 66. INDONESIA BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. INDONESIA BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 68. JAPAN BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 69. JAPAN BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 70. JAPAN BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. JAPAN BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 72. MALAYSIA BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 73. MALAYSIA BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 74. MALAYSIA BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. MALAYSIA BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 76. PHILIPPINES BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 77. PHILIPPINES BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 78. PHILIPPINES BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. PHILIPPINES BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 80. SINGAPORE BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 81. SINGAPORE BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 82. SINGAPORE BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. SINGAPORE BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 84. SOUTH KOREA BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 85. SOUTH KOREA BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH KOREA BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH KOREA BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 88. TAIWAN BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 89. TAIWAN BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 90. TAIWAN BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. TAIWAN BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 92. THAILAND BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 93. THAILAND BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 94. THAILAND BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. THAILAND BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 96. VIETNAM BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 97. VIETNAM BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 98. VIETNAM BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. VIETNAM BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 100. EUROPE, MIDDLE EAST & AFRICA BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA BLOOD CULTURE TEST MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 105. DENMARK BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 106. DENMARK BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 107. DENMARK BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 108. DENMARK BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 109. EGYPT BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 110. EGYPT BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 111. EGYPT BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 112. EGYPT BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 113. FINLAND BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 114. FINLAND BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 115. FINLAND BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 116. FINLAND BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 117. FRANCE BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 118. FRANCE BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 119. FRANCE BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 120. FRANCE BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 121. GERMANY BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 122. GERMANY BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 123. GERMANY BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 124. GERMANY BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 125. ISRAEL BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 126. ISRAEL BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 127. ISRAEL BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 128. ISRAEL BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 129. ITALY BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 130. ITALY BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 131. ITALY BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 132. ITALY BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 133. NETHERLANDS BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 134. NETHERLANDS BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 135. NETHERLANDS BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 136. NETHERLANDS BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 137. NIGERIA BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 138. NIGERIA BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 139. NIGERIA BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 140. NIGERIA BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 141. NORWAY BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 142. NORWAY BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 143. NORWAY BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 144. NORWAY BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 145. POLAND BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 146. POLAND BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 147. POLAND BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 148. POLAND BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 149. QATAR BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 150. QATAR BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 151. QATAR BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 152. QATAR BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 153. RUSSIA BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 154. RUSSIA BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 155. RUSSIA BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 156. RUSSIA BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 157. SAUDI ARABIA BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 158. SAUDI ARABIA BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 159. SAUDI ARABIA BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 160. SAUDI ARABIA BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 161. SOUTH AFRICA BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 162. SOUTH AFRICA BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 163. SOUTH AFRICA BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 164. SOUTH AFRICA BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 165. SPAIN BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 166. SPAIN BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 167. SPAIN BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 168. SPAIN BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 169. SWEDEN BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 170. SWEDEN BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 171. SWEDEN BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 172. SWEDEN BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 173. SWITZERLAND BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 174. SWITZERLAND BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 175. SWITZERLAND BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 176. SWITZERLAND BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 177. TURKEY BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 178. TURKEY BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 179. TURKEY BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 180. TURKEY BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 181. UNITED ARAB EMIRATES BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 182. UNITED ARAB EMIRATES BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED ARAB EMIRATES BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED ARAB EMIRATES BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED KINGDOM BLOOD CULTURE TEST MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED KINGDOM BLOOD CULTURE TEST MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED KINGDOM BLOOD CULTURE TEST MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED KINGDOM BLOOD CULTURE TEST MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 189. BLOOD CULTURE TEST MARKET, FPNV POSITIONING MATRIX, 2022
  • TABLE 190. BLOOD CULTURE TEST MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 191. BLOOD CULTURE TEST MARKET LICENSE & PRICING